Statins, Muscle Pain, and CoQ10

What the evidence actually says

At a Glance

• Muscle symptoms are common in adults who take statins, but a symptom occurring after a statin starts is not automatically caused by the medication.

• Blinded studies show that many symptoms experienced during statin treatment also occur during placebo treatment. The symptoms are real; the cause is not always the statin.

• A smaller group of people do have true statin-associated muscle symptoms or intolerance.

• Severe weakness, dark or cola-colored urine, markedly reduced urination, fever, or intense muscle pain requires prompt medical evaluation.

• Before giving up on statin therapy, clinicians can review interactions and other causes, change the dose or statin, use less-frequent dosing in selected cases, or use non-statin therapies.

• Statins lower blood levels of CoQ10, but this does not prove that muscle cells become CoQ10-deficient or that supplements prevent muscle symptoms.

• Current guidelines do not recommend routine CoQ10 for statin-associated muscle symptoms because trials have been small, mixed, and inconsistent.

In the first article, I made the case that the decision to take a statin should begin with your cardiovascular risk—not with fear of medication, and not with one cholesterol number.

But that leaves the question many readers asked in the poll:

If I need a statin and my muscles hurt, should I take CoQ10?

This deserves a better answer than either extreme.

It is not accurate to say that muscle symptoms on statins are imaginary, irrelevant, or simply “in your head.” It is also not accurate to assume that every ache that begins after a prescription is written must be caused by the statin, or that CoQ10 is a universal antidote.

The goal is to protect the heart while respecting the body.

That means taking symptoms seriously, being methodical about possible causes, recognizing the rare situations that require urgent attention, and using the evidence we have—not the marketing we are offered—to decide what comes next.

How statins work

Statins block an enzyme called HMG-CoA reductase in the liver. This enzyme is part of the pathway the body uses to make cholesterol.

When the liver produces less cholesterol internally, it responds by making more LDL receptors. Those receptors pull LDL and other ApoB-containing particles out of the bloodstream.

The result is fewer atherogenic particles circulating in the blood and fewer opportunities for those particles to enter the artery wall and contribute to plaque over time.

Depending on the medication and dose, statins can lower LDL cholesterol by roughly 30% to more than 50%. In people at meaningful cardiovascular risk, lowering LDL and ApoB-containing particles translates into fewer heart attacks, strokes, and other atherosclerotic events.¹

Statins also affect more than cholesterol production.

The same biochemical pathway contributes to the production of coenzyme Q10, or CoQ10, as well as other compounds involved in cellular signaling. That is the biologic basis for the concern that statins might affect muscle energy production and for the popular belief that everyone taking a statin should automatically take CoQ10.²

The biology is plausible. The clinical conclusion is less simple.

Muscle symptoms are real. The cause is often complicated.

Muscle pain is common in adulthood, whether or not someone takes a statin.

People develop soreness, cramps, fatigue, weakness, tendon problems, back pain, and joint pain for many reasons: exercise changes, aging, viral illness, poor sleep, dehydration, thyroid disease, vitamin deficiencies, inflammatory conditions, arthritis, alcohol use, new medications, and ordinary day-to-day life.

So when a symptom develops after a statin is started, timing alone cannot prove causation.

Large blinded trials are important here because neither the participant nor the clinician knows whether the person is receiving the statin or a placebo. In these studies, muscle symptoms are reported frequently in both groups, with only a small additional number attributable to the statin itself.³

In a large individual-participant meta-analysis of 19 placebo-controlled statin trials, 27.1% of people assigned a statin reported muscle pain or weakness, compared with 26.6% of people assigned placebo. The small excess was concentrated in the first year of treatment.³

The SAMSON study made this particularly vivid. It enrolled people who had stopped statins because of side effects and gave them alternating months of statin, placebo, and no tablets. Most of the symptom burden that occurred during statin months also occurred during placebo months.⁴

StatinWISE found a similar pattern: among people who had previously reported muscle symptoms with statins, symptom intensity was not meaningfully different during atorvastatin and placebo periods.⁵

This does not mean the symptoms were imagined.

Symptoms can be severe, disruptive, and completely real even when a drug is not the direct pharmacologic cause. Expectations, attention, prior experiences, natural changes in pain, and the understandable concern about a new medication can all influence what the body feels.

And a smaller group of people truly do experience statin-associated muscle symptoms.⁶,⁷

The clinical task is not to dismiss the person or to reflexively blame the medication. It is to determine the most likely explanation and find a treatment plan that remains both tolerable and protective.

What statin-related muscle symptoms usually look like

When muscle symptoms are related to a statin, they often involve aching, heaviness, cramping, tenderness, or fatigue in large, symmetrical muscle groups such as the thighs, buttocks, shoulders, or upper arms.⁶,⁷

Symptoms may begin within weeks to months of starting a medication or increasing a dose, though timing alone is not definitive. They may improve after stopping the statin and recur with a rechallenge, especially with the same medication and dose.⁶,⁷

But there is no single symptom pattern that proves the diagnosis.

Pain isolated to one shoulder, one knee, a single calf, or the low back may have another explanation. New severe weakness is different from soreness. Pain that started after a major change in exercise may be exercise-related. Cramping after illness, dehydration, or alcohol excess deserves a broader look.

That is why a careful history matters more than a generic online checklist.

Red flags: when to seek prompt care

Serious statin-related muscle injury is rare, but it is important to recognize.¹,⁶

Seek urgent medical evaluation for:

• Severe or rapidly progressive muscle weakness

• Intense or widespread muscle pain, especially if it is not explained by exercise or injury

• Dark, tea-colored, or cola-colored urine

• Markedly reduced urination

• Fever, severe malaise, or dehydration along with muscle symptoms

• Symptoms that occur with known kidney disease or after a major medication interaction

• A significant elevation in creatine kinase, often called CK, if testing has been performed

These symptoms can suggest rhabdomyolysis, a rare condition in which muscle breakdown can injure the kidneys.¹

This is not a situation to treat with CoQ10, hydration alone, or internet reassurance. It needs timely clinical assessment.

Before blaming the statin, review the full context

If muscle symptoms develop, the next step is not necessarily to stop the medication permanently. It is to understand what else may be contributing.

A clinician may review:

• The exact timing of symptoms relative to starting or changing the statin

• Location, symmetry, severity, and whether there is true weakness

• Recent increases in exercise, especially unfamiliar eccentric or strength training

• Dehydration, viral illness, fever, or major changes in alcohol intake

• Thyroid disease, kidney disease, liver disease, or other metabolic conditions

• Other medications and supplements

• Baseline and symptom-triggered laboratory tests when clinically appropriate

Testing is not required for every ache. But CK, thyroid studies, kidney and liver function, and other evaluation may be appropriate depending on the symptoms and medical context.⁷,⁸

Vitamin D deserves a measured discussion. Low vitamin D is common and can contribute to generalized muscle discomfort in some people, but routinely giving vitamin D solely to prevent statin muscle symptoms is not a proven solution. Test and treat when there is a clinical reason to do so, rather than turning it into another automatic supplement.⁷

Important medication interactions

Some cases of statin intolerance are not simply about the statin dose. They are about the statin dose plus another medication or substance that raises statin exposure.

Depending on the specific statin, relevant interactions can include:¹,⁷,⁹

• Grapefruit products, especially with simvastatin and lovastatin, and sometimes with higher atorvastatin exposure

• Certain macrolide antibiotics

• Azole antifungal medications

• Cyclosporine

• Some HIV or hepatitis C antiviral therapies

• Gemfibrozil and certain other triglyceride-lowering drugs

• Some calcium-channel blockers

• Other medications that affect liver enzymes or drug transport systems

This is one reason it is important to tell both the prescriber and pharmacist about prescription medications, over-the-counter products, and supplements.

It is also why “natural” does not always mean simpler.

Red yeast rice is a good example. Some preparations contain monacolin K, which is chemically identical to lovastatin. The amount can vary widely by product, quality control is inconsistent, and it can cause statin-like side effects and interactions.¹⁰,¹¹ Taking red yeast rice to avoid a prescription statin can mean taking an unpredictable, unmonitored version of one.

What to do if you think a statin is causing symptoms

If you have established coronary artery disease, a prior heart attack or stroke, peripheral artery disease, diabetes with high risk, very high LDL cholesterol, or other strong indications for lipid lowering, do not permanently discontinue treatment on your own.⁷

Contact the clinician who prescribed it. There are usually several options.

1. Pause and reassess when appropriate

For nonurgent symptoms, a clinician may recommend a brief pause to see whether symptoms improve. If they do, a carefully planned rechallenge can help determine whether the relationship is likely to be causal.⁷

This process is not meant to “prove you wrong.” It is meant to avoid permanently losing an effective therapy because of a coincidence—or continuing a medication that is genuinely not tolerable.

2. Try a different statin

Statins differ in dose, metabolism, potency, and how they are handled by the body.

A person who struggles with one statin may tolerate another. Some clinicians may choose a lower dose, a statin with fewer interaction concerns, or a more gradual titration.⁷,⁸

3. Consider less-frequent dosing in selected people

Because some statins have longer effects, intermittent dosing can be considered for selected patients who cannot tolerate daily therapy. It is not ideal for everyone, and the degree of LDL lowering may differ from standard daily treatment, but it can be better than abandoning lipid lowering altogether.⁷,⁸

4. Use combination or non-statin therapy when needed

Ezetimibe, bempedoic acid, PCSK9-targeting therapies, and other agents may be appropriate depending on your cardiovascular risk, LDL level, statin tolerance, other medical conditions, and insurance coverage.⁷,⁸

The right plan may be a lower statin dose plus another medication rather than an all-or-nothing choice.

The larger point is this: statin intolerance is not the same as lipid-lowering intolerance.⁷

Where CoQ10 fits into the story

CoQ10 is a naturally occurring compound involved in mitochondrial energy production. Mitochondria help cells convert oxygen and nutrients into ATP, the usable energy currency of the body. CoQ10 also functions as an antioxidant within cell membranes.

The body makes much of its own CoQ10, in part through the same biochemical pathway affected by statins.

Statins do lower circulating CoQ10 levels. But CoQ10 travels in the bloodstream largely on lipoproteins, including LDL particles. When statins lower LDL, blood CoQ10 levels may fall partly because there are fewer LDL particles carrying it.²

That observation alone does not establish that muscle cells are CoQ10-deficient.

Muscle-biopsy studies have not consistently shown that people taking statins have reduced CoQ10 inside muscle tissue, including among those who report symptoms.¹² Laboratory research has raised other plausible mechanisms, including effects of certain statin metabolites on mitochondrial energy production.¹³ Those findings are scientifically interesting, but they do not prove that most statin-associated symptoms result from CoQ10 depletion.

This distinction matters because plausible biology is not the same thing as a proven treatment.

Does CoQ10 prevent or treat statin muscle symptoms?

The short answer is: we do not know with enough confidence to recommend it routinely.

Clinical trials of CoQ10 for statin-associated muscle symptoms have been small, short, and inconsistent. Some analyses suggest a modest improvement in pain, cramping, weakness, or fatigue. Others find no meaningful benefit. The studies also differ in the type and dose of CoQ10 used, the statins involved, how symptoms were measured, and whether participants had symptoms that were clearly confirmed as statin-related.²,¹²,¹⁴

For those reasons, current guidelines do not recommend CoQ10 routinely to prevent or treat statin-associated muscle symptoms.⁸

That is not the same as saying no individual will ever feel better taking it.

For a person with persistent symptoms that have been thoughtfully evaluated, who has a meaningful need for lipid lowering, and who has already considered more established strategies—such as changing the statin, lowering the dose, adjusting frequency, or considering non-statin treatment—a clinician-supervised, time-limited trial of CoQ10 may be reasonable.² This is an individualized clinical judgment under uncertainty, not a guideline-endorsed treatment; the National Lipid Association does not currently recommend this strategy.⁷,⁸

But it should be a trial, not a lifelong assumption.

Define what symptom you are trying to improve. Decide how long you will test it. Keep other changes stable when possible. Then reassess honestly.

If it is not helping, there is no need to keep buying it.

CoQ10 safety and supplement reality

CoQ10 is generally well tolerated, but “generally well tolerated” is not the same as universally harmless or automatically appropriate.

It can cause gastrointestinal symptoms in some people.¹⁵ Supplements vary in formulation, dose, absorption, and quality. Labels do not always tell the full story.

CoQ10 may affect warfarin response in some people.¹⁵ If you take warfarin, do not start, stop, or substantially change CoQ10 without telling the clinician or anticoagulation service managing your INR.

If you are considering a CoQ10 product, choose one that has been independently tested when possible, and remember that a polished label is not proof of effectiveness.

Most importantly, do not use a supplement to delay evaluation of severe symptoms or to replace a lipid-lowering plan that is likely to protect you.

A practical path forward

If you are taking a statin and develop muscle symptoms, use this sequence:

1. Do not panic, but do not ignore severe symptoms. Seek prompt care for weakness, dark urine, reduced urination, fever, severe muscle pain, or other red flags.

2. Contact the prescriber before permanently stopping a statin, especially if you have known vascular disease, prior heart attack or stroke, diabetes with high risk, markedly elevated LDL cholesterol, or documented plaque.

3. Describe the symptoms precisely. When did they begin? Where are they? Is this soreness, cramping, fatigue, or actual weakness? Did your exercise, illness, hydration, alcohol intake, or medication list change?

4. Review possible contributors. This may include interacting medications, thyroid disease, kidney or liver disease, an exercise-related injury, or another cause of pain.

5. Use established medication strategies first. A pause and rechallenge, a different statin, a lower dose, intermittent dosing in selected patients, or a non-statin medication may all be reasonable depending on the situation.

6. Discuss CoQ10 afterward—not instead of assessment. If it is tried, treat it as a monitored, time-limited experiment rather than a guaranteed fix.

The integrative answer

Integrative medicine is often misunderstood as “natural instead of pharmaceutical.”

That is not how I think about it.

A genuinely integrative approach asks broader questions. What is driving this person’s risk? How do nutrition, movement, sleep, stress, metabolic health, medications, symptoms, family history, social circumstances, and personal preferences fit together? Which interventions are proven? Which are promising but uncertain? What is likely to help enough to justify the burden?

Sometimes the answer is a statin.

Sometimes it is a lower dose, a different statin, or a combination approach. Sometimes it is a non-statin therapy. Sometimes it is a serious commitment to lifestyle change alongside medication. Occasionally, after a careful evaluation, CoQ10 may be worth a monitored individual trial.

But the answer should not be reflexive.

You do not need to choose between being a thoughtful, health-conscious person and accepting appropriate medical treatment. And you do not need to accept side effects without asking for a better plan.

The goal is a prevention strategy you understand, trust, and can safely sustain.

---

Related reading

• Do You Really Need a Statin? How Risk, ApoB, and Calcium Scores Change the Answer

• Five Calcium Scores, Five Different Plans

• Yes, I Recommend Supplements. Here’s What I Wish Every Patient Knew About the Label.

This post is for general educational purposes only. It is not medical advice, is not a substitute for care from your own physician, and does not create a physician-patient relationship. Do not start, stop, or change any treatment based on what you read here. If you think you may have a medical emergency, call 911 or go to the nearest emergency department.

Also by Dr. Azhak: Lower Your Blood Pressure: Help Your Doctor Reduce Your Medication, by Sameer Azhak, MD, FACC. Available now on Kindle. Paperback launches October 20, 2026. Buy on Kindle

© 2026 Cordate Press

---

References

1. Newman CB, Preiss D, Tobert JA, et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2019;39:e38–e81. https://pubmed.ncbi.nlm.nih.gov/30580575/

2. Zaleski AL, Taylor BA, Thompson PD. Coenzyme Q10 as treatment for statin-associated muscle symptoms—a good idea, but… Adv Nutr. 2018;9:519S–523S. https://pubmed.ncbi.nlm.nih.gov/30032220/

3. Cholesterol Treatment Trialists’ Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022;400:832–845. https://pubmed.ncbi.nlm.nih.gov/36049498/

4. Wood FA, Howard JP, Finegold JA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects. N Engl J Med. 2020;383:2182–2184. https://www.nejm.org/doi/full/10.1056/NEJMc2031173

5. Herrett E, Williamson E, Brack K, et al. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials. BMJ. 2021;372:n135. https://www.bmj.com/content/372/bmj.n135

6. Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement. Eur Heart J. 2015;36:1012–1022. https://pubmed.ncbi.nlm.nih.gov/25694464/

7. Warden BA, Guyton JR, Kovacs AC, et al. Assessment and management of statin-associated muscle symptoms (SAMS): a clinical perspective from the National Lipid Association. J Clin Lipidol. 2023;17:19–39. https://pubmed.ncbi.nlm.nih.gov/36115813/

8. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026;87:2624–2757. https://www.jacc.org/doi/10.1016/j.jacc.2025.11.016

9. Wiggins BS, Saseen JJ, Page RL 2nd, et al. Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease. Circulation. 2016;134:e468–e495. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000456

10. Red yeast rice. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/red-yeast-rice

11. Red yeast rice. Mayo Clinic. https://www.mayoclinic.org/drugs-supplements-red-yeast-rice/art-20363074

12. Kovacic S, Habicht SD, Eckert GP. Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis. J Nutr Sci. 2025;14:e72. https://pmc.ncbi.nlm.nih.gov/articles/PMC12554813/

13. Schirris TJJ, Renkema GH, Ritschel T, et al. Statin-induced myopathy is associated with mitochondrial complex III inhibition. Cell Metab. 2015;22:399–407. https://pubmed.ncbi.nlm.nih.gov/26331605/

14. Qu H, Guo M, Chai H, et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e009835. https://www.ahajournals.org/doi/10.1161/JAHA.118.009835

15. Coenzyme Q10. Mayo Clinic. https://www.mayoclinic.org/drugs-supplements-coq10/art-20362602